Patents/Assignees

Verseau Therapeutics, Inc.

1 patent in portfolio

US12552873utility2026
Anti-psgl-1 Compositions and Methods for Modulating Myeloid Cell Inflammatory Phenotypes and Uses Thereof
0 cites